Abnormal methylation of several tumor suppressor genes in sporadic breast cancer

Molekulyarnaya Biologiya

Volumn 37, Issue 4, 2003, Pages 696-703

  Zemlyakova, V V ^a   Zhevlova, A I ^a   Strelnikov, V V ^c   Lyubchenko, L N ^b   Vishnevskaya, Ya V ^b   Tretyakova, V A ^a   Zaletayev, D V ^a,c   Nemtsova, M V ^a  

^a RESEARCH CENTRE FOR MEDICAL GENETICS   (Russian Federation)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^c I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; PROTEIN P14; PROTEIN P15; PROTEIN P16; UVOMORULIN;

ARTICLE; BREAST CANCER; CELL CYCLE REGULATION; CPG ISLAND; HUMAN; METHYLATION; POLYMERASE CHAIN REACTION; PROMOTER REGION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 10344263822     PISSN: 00268984     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Esteller M., Corn P., Baylin S., Herman J. 2001. A gene hypermethylation profile of human cancer. Cancer Res. 61, 3225-3229.
2. Hiltunen M.O., Koistinaho J., Myohanen S. et al. 1997. Hypermethylation of the APC gene promoter region in human colorectal carcinoma. Int. J. Cancer. 70, 644-648.
3. Kane M.F., Loda M., Gaida G. et al. 1997. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 57, 808-811.
4. Iida S., Akiyama Y., Nakajima T. et al. 2000. Alterations and hypermethylation of p14ARF gene in gastric cancer. Int. J. Cancer. 87, 654-658.
5. Herman J., Civin C., Issa J. et al. 1997. Distinct pattern of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res. 57, 837-841.
6. Tchou J.C., Lin X., Freije D. et al. 2000. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas. Int. J. Oncol. 16, 663-676.
7. Ferguson A.T., Evron E., Umbricht C.B. et al. 2000. High frequency of hypermethylation at the 14-3-3σ locus leads to gene silencing in breast cancer. Pros. Natl. Acad. Sci. USA. 97, 6049-6054.
8. Virmani A.K., Rathi A., Sathyanarayana G. et al. 2001. Aberrant methylation of the Adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin. Cancer Res. 7, 1998-2004.
9. Zochbauer-Muller S., Fong K.M., Maitra A. et al. 2001. 5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and cancer. Cancer Res. 61, 3581-3585.
10. Yang Q., Nakamura M., Nakamura Y. et al. 2002. Two-hit inactivation of FHIT by loss heterozygosity and hypermethylation in breast cancer. Clin. Cancer Res. 8, 2890-2893.
11. Yuan Y., Mendez R., Sahin A. et al. 2001. Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res. 61, 5558-5561.
12. Dammann R., Yang G., Pfeifer G.P. 2001. Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res. 61, 3105-3109.
13. Dallol A., Fernandes Da Silva N., Viacava P. et al. 2002. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Cancer Res. 62, 5874-5880.
14. Xu L.X., Wu L.C., Du F. et al. 2001. Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers. Cancer Res. 61, 7943-7949.
15. Jones P., Leard P. 1999. Cancer epigenetics comes of age. Nature Genet. 21, 163-167.
16. Bird A., Wolffe A. 1999. Methylation-induced repression-belts, braces, and chromatin. Cell. 99, 451-454.
17. Sambrook J., Fritsh E.F., Maniatis T. 1989. Molecular cloning: a laboratory manual. 2nd ed. N. Y.: Cold Spring Harbor Laboratory Press.
18. INK4A (MTS1) in B-cell and T-cell lymphomas. Blood. 94, 1773-1781.
19. Graff J.R., Herman J.R., Myohanen S. et al. 1997. Mapping patterns of CpG island methylation in normal and neoplastic cells implicated both upstream and down-stream region in de novo methylation. J. Biol. Chem. 227, 22322-22329.
20. Konishi N., Nakamura M., Kishi M. et al. 2002. DNA hypermethylation status of multiple genes in prostate adenocarcinomas. Jpn. J. Cancer Res. 93, 767-773.
21. Fujii H., Biel M.A., Zhou W. et al. 1998. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer. Oncogene. 16, 2159-2164.
22. Li Q., Jedlicka A., Ahuja N. et al. 1998. Concordant methylation of the ER and N33 genes in glioblastoma multiform. Oncogene. 16, 3197-3202.
23. Hirama T., Koeffler H. 1995. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood. 86, 841-854.
24. Orlow I., Lacombe L., Hannot G. et al. 1995. Deletion of the p15 and p16 genes in human bladder tumors. Jpn. Natl. Cancer Inst. 87, 1524-1529.
25. Cairns P., Polascik T., Eby Y. et al. 1995. Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nature Genet. 11, 210-212.
26. Sakai T., Toguchida J., Ohtani N. et al. 1991. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am. J. Human Genet. 48, 880-888.
27. Lohmann D.R., Gerick M., Brandt B. et al. 1997. Constitutional RB1-gene mutation in patient with isolated unilateral retinoblastoma. Am. J. Human Genet. 61, 282-294.
28. Nakamura M., Yonekawa Y., Kleihues P. et al. 2001. Promoter hypermethylation of the RB1 gene in glioblastomas. Laboratory Investigation. 81, 77-82.
29. Geradts J., Fong K., Zimmerman P. et al. 1999. Correlation of abnormal RB1, p16(INK4a) and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers. Clin. Cancer Res. 5, 791-800.
30. ARF encoding exons in T-cell acute lymphoblastic leukemia. Blood. 91, 1016-1020.
31. Xing E., Nie Y., Song Y., Uang G.-Y. et al. 1999. Mechanism of inactivation of p14(ARF), p15(INK4b) and p16(INK4a) genes in human esophageal cell carcinoma. Clin. Cancer Res. 5, 2704-2713.
32. Kim D-H., Nelson H.H., Wiencke J.K. et al. 2001. p16/INK4A and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small lung cancer. Cancer Res. 61, 3419-3424.
33. Herman J.G., Merlo A., Mao L. et al. 1995. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55, 4525-4530.
34. Woodcock D.M., Linsenmeyer M.E., Doherty J.P. et al. 1999. DNA methylation in the promoter region of the p16 (CDKN2/MTS-1/INK4A) gene in human breast tumors. Brit. J. Cancer. 79, 251-256.
35. Kiono T., Foster S.A., Koop J.I. et al. 1998. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature. 396, 84-89.
36. Jarrard D.F., Sarkar S., Yeager T.R. et al. 1999. p16/pRb pathway alteration are required for bypassing senescence in human prostate epithelial cells. Cancer Res. 59, 2957-2964.
37. Zochbauer-Muller S., Fong K., Virmani A. et al. 2001. Aberrant promoter methylation of multiple genes in non-small cell lung cancer. Cancer Res. 61, 249-255.
38. Toyota M., Ahuja N., Suzuki H. et al. 1999. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 59, 5438-5442.
39. Nass S.J., Herman J.G., Gabrielson E. et al. 2000. Aberrant methylation of the estrogsn receptor and E-cadherin 5′ CpG islands increases with malignant progression in human breast cancer. Cancer Res. 60, 4346-4348.
40. Wales M.M., Biel M.A., Deiry W. et al. 1995. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nature Medicine. 1, 570-577.
41. Baylin S.B., Herman J.G., Graff J.R. et al. 1998. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 72, 141-196.
42. Bova G.S., MacGrogan D., Levy A. et al. 1996. Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer. Genomics. 35, 46-54.
43. MacGrogan D., Levy A., Bova G.S. et al. 1996. Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22. Genomics. 35, 55-65.
44. Ahuja N., Li Q., Baylin S.B. et al. 1998. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 58, 5489-5494.